Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (61-70 of 308) with videos related to

Pageof 31
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|April 27, 2024
Chief Complaint: Nasal CongestionRichard John Harvey, Lauren T Roland, Rodney J Schlosser, et al.
International Archives of Allergy and Immunology|May 17, 2018
Reliability of a New Symptom Score in a Titrated Quantitative Conjunctival Provocation Test Supported by an Objective PhotodocumentationOliver Pfaar, Dan Philipp Claßen, Anatoli Astvatsatourov, et al.
Clinical and Translational Allergy|December 26, 2023
Clinical relevance of pre- and coseasonal sublingual immunotherapy with a 300 index of reactivity 5-grass SLIT tablet in allergic rhinoconjunctivitisOliver Pfaar, Ulrich Wahn, Giorgio Walter Canonica, et al.
Clinical and Translational Allergy|May 25, 2023
Persistence in allergen immunotherapy: A longitudinal, prescription data-based real-world analysisOliver Pfaar, Hartmut Richter, Angelika Sager, et al.
Allergo Journal International|May 27, 2016
Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in GermanyRandolf Brehler, Ludger Klimek, Christian Vogelberg, et al.
Chemical Senses|November 25, 2005
Mechanical obstruction of the olfactory cleft reveals differences between orthonasal and retronasal olfactory functionsOliver Pfaar, Basile Nicolas Landis, Johannes Frasnelli, et al.
The World Allergy Organization Journal|August 27, 2025
Atopic dermatitis occurrence and progression and allergen immunotherapy: A real-world, retrospective cohort study in GermanyOliver Pfaar, Hartmut Richter, Thomas Müller, et al.
Clinical and Translational Allergy|October 13, 2022
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long-term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitisNatalija Novak, Margitta Worm, Petra Staubach, et al.
Allergy and Asthma Proceedings|July 10, 2010
Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extractsRandolf Brehler, Ludger Klimek, Oliver Pfaar, et al.
Clinical and Translational Allergy|December 24, 2013
The placebo effect in allergen-specific immunotherapy trialsAnnemie Narkus, Ulrike Lehnigk, Dietrich Haefner, et al.
Pageof 31

Showing results (61-70 of 308) with videos related to

Sort By:
Pageof 31
The Journal of Allergy and Clinical Immunology. in Practice|April 27, 2024
Chief Complaint: Nasal CongestionRichard John Harvey, Lauren T Roland, Rodney J Schlosser, et al.
International Archives of Allergy and Immunology|May 17, 2018
Reliability of a New Symptom Score in a Titrated Quantitative Conjunctival Provocation Test Supported by an Objective PhotodocumentationOliver Pfaar, Dan Philipp Claßen, Anatoli Astvatsatourov, et al.
Clinical and Translational Allergy|December 26, 2023
Clinical relevance of pre- and coseasonal sublingual immunotherapy with a 300 index of reactivity 5-grass SLIT tablet in allergic rhinoconjunctivitisOliver Pfaar, Ulrich Wahn, Giorgio Walter Canonica, et al.
Clinical and Translational Allergy|May 25, 2023
Persistence in allergen immunotherapy: A longitudinal, prescription data-based real-world analysisOliver Pfaar, Hartmut Richter, Angelika Sager, et al.
Allergo Journal International|May 27, 2016
Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in GermanyRandolf Brehler, Ludger Klimek, Christian Vogelberg, et al.
Chemical Senses|November 25, 2005
Mechanical obstruction of the olfactory cleft reveals differences between orthonasal and retronasal olfactory functionsOliver Pfaar, Basile Nicolas Landis, Johannes Frasnelli, et al.
The World Allergy Organization Journal|August 27, 2025
Atopic dermatitis occurrence and progression and allergen immunotherapy: A real-world, retrospective cohort study in GermanyOliver Pfaar, Hartmut Richter, Thomas Müller, et al.
Clinical and Translational Allergy|October 13, 2022
Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long-term efficacy in a subgroup of monosensitized adults and adolescents with allergic rhinitisNatalija Novak, Margitta Worm, Petra Staubach, et al.
Allergy and Asthma Proceedings|July 10, 2010
Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extractsRandolf Brehler, Ludger Klimek, Oliver Pfaar, et al.
Clinical and Translational Allergy|December 24, 2013
The placebo effect in allergen-specific immunotherapy trialsAnnemie Narkus, Ulrike Lehnigk, Dietrich Haefner, et al.
Pageof 31